<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: stroke treatment</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>What impacts whether African Americans call 9-1-1 immediately for stroke symptoms?</title>
   	 <description>African-Americans know the signs of stroke, but concerns about medical cost, ambulance response time and unfamiliarity with the need for prompt hospital care impacted whether they called 9-1-1 immediately.</description>
     <link>http://medicalxpress.com/news/2013-05-impacts-african-americans-immediately.html</link>
	 <category>Cardiology</category>
	 <pubDate>Tue, 14 May 2013 16:00:03 EST</pubDate>
	 <guid isPermaLink="false">news287758285</guid>
	 
</item>
<item>
     <title>Do blood thinners + stroke treatment = danger? Study indicates the risk is low</title>
   	 <description>Millions of Americans take aspirin or other drugs every day to reduce their risk of heart attacks or other problems caused by blood clots.</description>
     <link>http://medicalxpress.com/news/2013-03-blood-thinners-treatment-danger.html</link>
	 <category>Cardiology</category>
	 <pubDate>Wed, 13 Mar 2013 10:10:33 EST</pubDate>
	 <guid isPermaLink="false">news282388225</guid>
	 
</item>
<item>
     <title>Delay in breaking up blood clots means worse stroke outcome</title>
   	 <description>Every 30-minute delay in breaking up a blood clot from a stroke was associated with a 10 percent decrease in the probability of a good outcome, regardless of other factors such as stroke severity, according to late-breaking research presented at the American Stroke Association's International Stroke Conference 2013.</description>
     <link>http://medicalxpress.com/news/2013-02-blood-clots-worse-outcome.html</link>
	 <category>Cardiology</category>
	 <pubDate>Mon, 11 Feb 2013 06:20:01 EST</pubDate>
	 <guid isPermaLink="false">news279785415</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/delayinbreak.jpg" width="90" height="90" />
</item>
<item>
     <title>Adding endovascular therapy to tPA didn't improve recovery after stroke</title>
   	 <description>Adding endovascular therapy to clot-busting therapy for stroke did not significantly improve stroke recovery at three months, according to a study presented in a special symposium at the American Stroke Association's International Stroke Conference 2013.</description>
     <link>http://medicalxpress.com/news/2013-02-adding-endovascular-therapy-tpa-didnt.html</link>
	 <category>Cardiology</category>
	 <pubDate>Fri, 08 Feb 2013 05:50:01 EST</pubDate>
	 <guid isPermaLink="false">news279524104</guid>
	 
</item>
<item>
     <title>Medical societies unite on patient-centered measures for nonsurgical stroke interventions</title>
   	 <description>The first outcome-based guidelines for interventional treatment of acute ischemic stroke—providing recommendations for rapid treatment—will benefit individuals suffering from brain attacks, often caused by artery-blocking blood clots. Representatives from the Society of Interventional Radiology and seven other medical societies created a multispecialty and international consensus on the metrics and benchmarks for processes of care and technical and clinical outcomes for stroke patients.</description>
     <link>http://medicalxpress.com/news/2013-01-medical-societies-patient-centered-nonsurgical-interventions.html</link>
	 <category>Cardiology</category>
	 <pubDate>Tue, 29 Jan 2013 10:02:54 EST</pubDate>
	 <guid isPermaLink="false">news278676108</guid>
	 
</item>
<item>
     <title>Stroke survivors with PTSD more likely to avoid treatment</title>
   	 <description>A new survey of stroke survivors has shown that those with post-traumatic stress disorder (PTSD) are less likely to adhere to treatment regimens that reduce the risk of an additional stroke. Researchers found that 65 percent of stroke survivors with PTSD failed to adhere to treatment, compared with 33 percent of those without PTSD. The survey also suggests that nonadherence in PTSD patients is partly explained by increased ambivalence toward medication. Among stroke survivors with PTSD, approximately one in three (38 percent) had concerns about their medications. Results of the study, led by Columbia University Medical Center researchers, are published today in the British Journal of Health Psychology.</description>
     <link>http://medicalxpress.com/news/2013-01-survivors-ptsd-treatment.html</link>
	 <category>Psychology &amp; Psychiatry</category>
	 <pubDate>Fri, 18 Jan 2013 00:00:01 EST</pubDate>
	 <guid isPermaLink="false">news277661759</guid>
	 
</item>
<item>
     <title>Telestroke networks can be cost-effective for hospitals, good for patients</title>
   	 <description>Telestroke networks that enable the remote and rapid diagnosis and treatment of stroke can improve the bottom line of patients and hospitals, researchers report.</description>
     <link>http://medicalxpress.com/news/2012-12-telestroke-networks-cost-effective-hospitals-good.html</link>
	 <category>Cardiology</category>
	 <pubDate>Mon, 17 Dec 2012 11:00:58 EST</pubDate>
	 <guid isPermaLink="false">news274964445</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/telestrokene.jpg" width="90" height="84" />
</item>
<item>
     <title>Double duty: Immune system regulator found to protect brain from effects of stroke</title>
   	 <description>A small molecule known to regulate white blood cells has a surprising second role in protecting brain cells from the deleterious effects of stroke, Johns Hopkins researchers report. The molecule, microRNA-223, affects how cells respond to the temporary loss of blood supply brought on by stroke—and thus the cells' likelihood of suffering permanent damage.</description>
     <link>http://medicalxpress.com/news/2012-11-duty-immune-brain-effects.html</link>
	 <category>Immunology</category>
	 <pubDate>Wed, 28 Nov 2012 14:48:07 EST</pubDate>
	 <guid isPermaLink="false">news273336473</guid>
	 
</item>
<item>
     <title>Stroke patients benefit from carmaker's efficiency</title>
   	 <description>A process developed to increase efficiency and productivity in Japanese car factories has helped improve stroke treatment at Barnes-Jewish Hospital, report researchers at Washington University School of Medicine in St. Louis.</description>
     <link>http://medicalxpress.com/news/2012-10-patients-benefit-carmaker-efficiency.html</link>
	 <category>Cardiology</category>
	 <pubDate>Thu, 18 Oct 2012 16:00:07 EST</pubDate>
	 <guid isPermaLink="false">news269786421</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/strokepatien.jpg" width="90" height="90" />
</item>
<item>
     <title>Stroke blood test that could increase use of most effective treatment five-fold</title>
   	 <description>Researchers at the University of Geneva (UNIGE), in collaboration with UK company Proteome Sciences plc (PS) describe a simple blood test that could substantially increase the number of patients eligible for highly effective ischaemic stroke therapy in a paper &quot;Blood Glutathione S-Transferase-pi (GSTP) as a Time Indicator of Stroke Onset&quot;, published last week in the journal PLoS ONE. </description>
     <link>http://medicalxpress.com/news/2012-09-blood-effective-treatment-five-fold.html</link>
	 <category>Cardiology</category>
	 <pubDate>Thu, 20 Sep 2012 06:22:44 EST</pubDate>
	 <guid isPermaLink="false">news267340957</guid>
	 
</item>
<item>
     <title>Researchers discover drug target for stimulating recovery from stroke</title>
   	 <description>Investigators at the Stanford University School of Medicine have shown that removing a matched set of molecules that typically help to regulate the brain's capacity for forming and eliminating connections between nerve cells could substantially aid recovery from stroke even days after the event. In experiments with mice, the scientists demonstrated that when these molecules are not present, the mice's ability to recover from induced strokes improved significantly.</description>
     <link>http://medicalxpress.com/news/2012-03-drug-recovery.html</link>
	 <category>Neuroscience</category>
	 <pubDate>Wed, 21 Mar 2012 13:15:33 EST</pubDate>
	 <guid isPermaLink="false">news251554444</guid>
	 
</item>
<item>
     <title>Scientists develop world's most advanced drug to protect the brain after a stroke</title>
   	 <description>Scientists at the Toronto Western Research Institute (TWRI), Krembil Neuroscience Center, have developed a drug that protects the brain against the damaging effects of a stroke in a lab setting. This drug has been in development for a few years. At this point, it has reached the most advanced stage of development among drugs created to reduce the brain's vulnerability to stroke damage (termed a &quot;neuroprotectant&quot;). Over 1000 attempts to develop such drugs by scientists worldwide have failed to be translated to a stage where they can be used in humans, leaving a major unmet need for stroke treatment. The drug developed by the TWRI team is the first to achieve a neuroprotective effect in the complex brain of primates, in settings that simulate those of human strokes. ischemic stroke.</description>
     <link>http://medicalxpress.com/news/2012-02-scientists-world-advanced-drug-brain.html</link>
	 <category>Medical research</category>
	 <pubDate>Wed, 29 Feb 2012 13:54:13 EST</pubDate>
	 <guid isPermaLink="false">news249746047</guid>
	 
</item>
<item>
     <title>Dash to help - new app to improve stroke treatment</title>
   	 <description>The Newcastle team who helped develop the FAST system to identify a stroke are now piloting an app to ensure the best treatment for stroke patients.</description>
     <link>http://medicalxpress.com/news/2012-02-dash-app-treatment.html</link>
	 <category>Health</category>
	 <pubDate>Fri, 17 Feb 2012 11:14:37 EST</pubDate>
	 <guid isPermaLink="false">news248699666</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/dashtohelpne.jpg" width="90" height="90" />
</item>
<item>
     <title>University of Kentucky offers stroke stem cell trial</title>
   	 <description>The University of Kentucky will be the first site in the state and one of a select few in the entire country participating in the first stages of a groundbreaking study to investigate the effects of MultiStem, a human adult stem cell product, on patients with acute ischemic stroke. The phase II clinical trial, known as Atherys stroke protocol B01-02, was recently approved by UK's institutional review board.</description>
     <link>http://medicalxpress.com/news/2012-01-university-kentucky-stem-cell-trial.html</link>
	 <category>Medical research</category>
	 <pubDate>Fri, 13 Jan 2012 11:40:01 EST</pubDate>
	 <guid isPermaLink="false">news245676554</guid>
	 
</item>
<item>
     <title>New clue to brain bleeding after stroke treatment</title>
   	 <description>The only medication currently approved for stroke treatment &amp;#150; tissue plasminogen activator (tPA), which dissolves blood clots &amp;#150; is associated with an increased risk of bleeding in the brain, particularly among patients with hyperglycemia (high blood sugar). A study led by Raymond A. Swanson, MD, chief of the neurology and rehabilitation service at the San Francisco VA Medical Center, provides a possible reason: high blood sugar fuels the formation of superoxide, a toxic form of oxygen, which in turn damages tissues, weakens blood vessels and promotes excess bleeding.</description>
     <link>http://medicalxpress.com/news/2011-10-clue-brain-treatment.html</link>
	 <category>Neuroscience</category>
	 <pubDate>Mon, 17 Oct 2011 09:26:22 EST</pubDate>
	 <guid isPermaLink="false">news238062360</guid>
	 
</item>
<item>
     <title>Brain Attack Coalition updates recommendations for Primary Stroke Centers</title>
   	 <description>Stroke patients who need emergency care should be taken to the nearest certified primary stroke center, which acts as a central point for stroke treatment, according to recommendations from the Brain Attack Coalition (BAC), a group representing medical, scientific, nonprofit and government leaders in the field of stroke. The recommendations, which reflect advances in stroke treatment over the past decade, are published online in the September issue of the journal Stroke.</description>
     <link>http://medicalxpress.com/news/2011-08-brain-coalition-primary-centers.html</link>
	 <category>Cardiology</category>
	 <pubDate>Fri, 26 Aug 2011 09:58:40 EST</pubDate>
	 <guid isPermaLink="false">news233571506</guid>
	 
</item>
<item>
     <title>New research identifies key reasons racial disparities exist in emergent stroke treatment</title>
   	 <description>African-Americans are less likely than whites to receive critical stroke treatment primarily because they do not get to a hospital soon enough for time-sensitive treatment and because of preexisting medical conditions.  For patients who are eligible for treatment, no racial disparity was found.</description>
     <link>http://medicalxpress.com/news/2011-06-key-racial-disparities-emergent-treatment.html</link>
	 <category>Cardiology</category>
	 <pubDate>Thu, 30 Jun 2011 17:26:28 EST</pubDate>
	 <guid isPermaLink="false">news228673568</guid>
	 
</item>


</channel>
</rss>
